SEP 14·SEC EDGARLow
Minan Peter Francis purchased $474 of USPH
Minan Peter Francis purchased 6 shares of U S PHYSICAL THERAPY INC /NV (USPH) at an average of $77.23 ($66.50–$79.00) across 2 trades over 2026-06-12 to 2026-09-11.
StockNYSE · US · USDHealthcare · Medical Care Facilities
$USPH
U S PHYSICAL THERAPY INC /NV
Price · $USPHvia TradingView
AI sentiment · 7d1 articles
- Bullish
- 0
- Neutral
- 1
- Bearish
- 0
Insider · 30dAll trades →
- Buys
- $416 1 txs
- Sells
- — 0 txs
Minan Peter Francis1× · $416
10b5-1 share of filings0%
Top stories · $USPHMore →
SEP 14·insidermonkey.com
US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO
US Physical Therapy (USPH) appointed Nchacha Etta as CFO, effective September 1. Etta previously held CFO roles at Omnicell (OMCL) and Johnson & Johnson Vision. USPH reported Q2 2026 revenue of $214.1M, up 8.5%, but net income fell to $9.9M from $12.4M. The company reaffirmed full-year adjusted EBITDA guidance of $102M-$106M.
AUG 15·finance.yahoo.com
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)
The article highlights Q2 results for outpatient and specialty care firms. Surgery Partners (SGRY) reported slowest revenue growth and weaker full-year guidance, with the stock down 1.4% to $15.32. LifeStance (LFST) revenue rose to $435.4M (+26.1%) and shares rose 18.3% to $12.27. U.S. Physical Therapy (USPH) revenue $214.1M (+8.5%) and shares $81.96. Encompass Health (EHC) revenue $1.60B (+9.6%) and shares $124.69. agilon health (AGL) revenue $1.49B (+7.2%), shares $87.56.
USPH sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 1 news story mentioning USPH (U S PHYSICAL THERAPY INC /NV). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent USPH coverage spans financial news, earnings and insider activity.
In the last 30 days, USPH insiders filed 1 SEC Form 4 transaction — 1 purchase ($416) and no sales. The most active reporter was Minan Peter Francis with 1 filing.
What's driving USPH
Small insider purchase signals confidence but limited market impact due to low dollar amount.
CFO transition is a near-term governance and execution signal, but the bigger trading driver is the disclosed margin compression, higher debt, and reaffirmed EBITDA range.
Mixed print suggests investors are rewarding revenue resilience while discounting EPS weakness, leaving earnings quality as the key watch item.
New CFO employment terms and compensation package can shift near-term governance expectations and investor sentiment, but no financial guidance or operating metrics are disclosed.
Hospital-affiliation expansion is driving visit and net-rate lift, but PT margins are pressured by medical costs and front-loaded implementation costs.
AlphAI scores every news story that mentions USPH with an AI model for sentiment and relevance, and aggregates insider trades from U S PHYSICAL THERAPY INC /NV's SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $USPH
Score
Minan Peter Francis purchased $474 of USPH
Minan Peter Francis purchased 6 shares of U S PHYSICAL THERAPY INC /NV (USPH) at an average of $77.23 ($66.50–$79.00) across 2 trades over 2026-06-12 to 2026-09-11.
1 min read
US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO
US Physical Therapy (USPH) appointed Nchacha Etta as CFO, effective September 1. Etta previously held CFO roles at Omnicell (OMCL) and Johnson & Johnson Vision. USPH reported Q2 2026 revenue of $214.1M, up 8.5%, but net income fell to $9.9M from $12.4M. The company reaffirmed full-year adjusted EBITDA guidance of $102M-$106M.
6 min read
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)
The article highlights Q2 results for outpatient and specialty care firms. Surgery Partners (SGRY) reported slowest revenue growth and weaker full-year guidance, with the stock down 1.4% to $15.32. LifeStance (LFST) revenue rose to $435.4M (+26.1%) and shares rose 18.3% to $12.27. U.S. Physical Therapy (USPH) revenue $214.1M (+8.5%) and shares $81.96. Encompass Health (EHC) revenue $1.60B (+9.6%) and shares $124.69. agilon health (AGL) revenue $1.49B (+7.2%), shares $87.56.
6 min readU S PHYSICAL THERAPY INC /NV (USPH): Entry into a Material Definitive Agreement
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (“Agreement”) is entered into and effective as of the 12th day of August, 2026, by and between U. S. Physical Therapy, Inc. a Nevada corporation (“Employer”) and Nchacha Etta (“Employee”). Employer and Employee may be re
4 min read
USPH (USPH) Q2 2026 Earnings Call Transcript
US Physical Therapy (USPH) discussed its Q2 2026 results and hospital-affiliation rollout. The company said Q2 revenue rose 8.5% to $214M, PT revenue rose 8.4% to $182M, and visits increased 6.6% to 1.662M. Net rate was $107.59. It cited $3.2M higher self-insured health care costs and expects clinic transitions to continue into Q3.
7 min readU.S. Physical Therapy (USPH): Return Expectations Tempered Despite Solid Execution
Conestoga Capital Advisors’ Q2 2026 investor letter says small caps strengthened, with the Russell 2000 up and Russell 2000 Growth up 25.7% in Q2. The firm discussed U.S. Physical Therapy (NYSE:USPH), an outpatient clinic operator, and said it sold the position due to labor cost pressures, reimbursement uncertainty, and slower margin growth, despite solid rehab demand. USPH closed at $76.46 on Aug. 6, 2026.
4 min readU S PHYSICAL THERAPY INC /NV (USPH): Results of Operations and Financial Condition
U S PHYSICAL THERAPY INC /NV (USPH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 CONTACT: U.S. Physical Therapy, Inc. Jason Curtis, Interim Chief Financial Officer email: jcurtis@usph.com Chris Reading, Chief Executive Officer (713) 297-7000 Three Part Advisors Joe Noyons (817) 778-8424 USPH Reports Second Quarter 2026 Results, Reaffirms Full Yea
6 min read
Earnings To Watch: U.S. Physical Therapy (USPH) Reports Q2 Results Tomorrow
U.S. Physical Therapy (NYSE: USPH) will report Q2 earnings Wednesday after the bell. The company previously reported $198.3M revenue, up 7.9% YoY, but missed EPS estimates. For the upcoming quarter, analysts expect revenue up 6.4% YoY. The article cites an average analyst price target of $93.67 versus $77.88 and notes peer results from Centene and Tenet.
3 min readMinan Peter Francis purchased $49K of USPH
Minan Peter Francis purchased 780 shares of U S PHYSICAL THERAPY INC /NV (USPH) at an average of $62.53 ($61.50–$63.14) across 2 trades over 2026-06-08 to 2026-06-09.
1 min read
U.S. Physical Therapy’s (NYSE:USPH) Q1 CY2026 Earnings Results: Revenue In Line With Expectations
U.S. Physical Therapy (NYSE: USPH) reported Q1 CY2026 earnings with revenue of $198.3 million, meeting analyst expectations, but a GAAP loss of $0.12 per share, significantly missing estimates. The company's adjusted EBITDA also fell below projections, and its operating margin decreased year-over-year. Despite these challenges, the company highlighted new initiatives aimed at improving efficiency and care, expecting them to bear fruit in the latter half of the year.
3 min read